Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges

  1. Abdullahi, I.N.
  2. Emeribe, A.U.
  3. Adekola, H.A.
  4. Abubakar, S.D.
  5. Dangana, A.
  6. Shuwa, H.A.
  7. Nwoba, S.T.
  8. Mustapha, J.O.
  9. Haruna, M.T.
  10. Olowookere, K.A.
  11. Animasaun, O.S.
  12. Ugwu, C.E.
  13. Onoja, S.O.
  14. Gadama, A.S.
  15. Mohammed, M.
  16. Daneji, I.M.
  17. Amadu, D.O.
  18. Ghamba, P.E.
  19. Onukegbe, N.B.
  20. Shehu, M.S.
  21. Isomah, C.
  22. Babayo, A.
  23. Ahmad, A.E.-F.
Revue:
Human Vaccines and Immunotherapeutics

ISSN: 2164-554X 2164-5515

Année de publication: 2021

Volumen: 17

Número: 3

Pages: 620-637

Type: Révision

DOI: 10.1080/21645515.2020.1812313 GOOGLE SCHOLAR lock_openAccès ouvert editor
Dépôt institutionnel: lock_openAccès ouvert Editor